Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group
(Q74038855)
scientific article published on 01 January 1998
scientific article published on 01 January 1998
Language:
Current Data About
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group
other details
| description | scientific article published on 01 January 1998 |
External Links
| (P356) |
10.1056/NEJM199801153380304
|
| (P698) |
9428817
|